Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
0.7690
-0.0150 (-1.91%)
At close: Jul 11, 2025, 4:00 PM
0.7736
+0.0046 (0.60%)
After-hours: Jul 11, 2025, 6:56 PM EDT
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $59.86 million as of July 11, 2025. Its market cap has decreased by -0.30% in one year.
Market Cap
59.86M
Enterprise Value
27.04M
1-Year Change
-0.30%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has increased from $45.05M to $59.86M, an increase of 32.89%. That is a compound annual growth rate of 6.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 61.03M | -4.94% |
| Dec 31, 2024 | 64.19M | -19.95% |
| Dec 29, 2023 | 80.19M | 35.27% |
| Dec 30, 2022 | 59.28M | -88.32% |
| Dec 31, 2021 | 507.73M | 1,027.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |